TrialClinical cancer research : an official journal of the American Association for Cancer Research2021

RELAY Subgroup Analyses by EGFR Ex19del and Ex21L858R Mutations for Ramucirumab Plus Erlotinib in Metastatic Non-Small Cell Lung Cancer.

Kazuhiko Nakagawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.